(1)Medical Microbiology Specialist, Medical Microbiology Unit, Angios Vascular Center & Wound Clinic, Caracas, Venezuela.
(2)Pharmacist & Chemistry MSc., founder of Microbiología Farmacéutica. San Jose, Costa Rica
*Corresponding author:Franklin Binns; E-mail: email@example.com
Submission: March 19, 2020; Published: July 10, 2020
Volume1 Issue1 March 2020
Bacterial Endotoxin Tests (BETs) are critical for the control and release of raw material in the biomedical devices industries, and for the quality assurance and release of finished products from the manufacturer to the distributor and finally to the consumer (in many cases, the patient). As one of the most interesting poles for the growing of the biomedical devices industries, Costa Rica has emerged as a leading global destination, outside Europe, for investment in Medical Technology, attracting 47 such projects in a period of 5 years, including 18 in 2012, and positioning itself as #7 at the level global in terms of the number of manufacturing projects, beating Holland, Brazil and Mexico, between 2008 and 2012 . The country has evolved over the years, and has gone from producing Class I to Class III medical devices, including those in areas of medical-aesthetic, cardiovascular, endoscopy, cardiovascular, dental, drug delivery systems, neuro-endovascular, neuro-modulation, optical, orthopedic / sports medicine / ENT and surgical / diagnostic; which now serve markets in America, Europe, Asia and Oceania. Costa Rica is now the second largest exporter of Medical Devices in Latin America.